In summary, this study highlights the critical role of TXNIP in HSV-1 and DENV2 infections and elucidates the molecular mechanism by which TXNIP attenuates the host's antiviral immune response by inhibiting MAVS aggregation and the TBK1-IRF3 signaling pathway. Here, IRF3 is linked to infection.